The global ornithine aspartate (LOLA) market is expected to grow at a CAGR of 5.5% during the forecast period. Ornithine aspartate (LOLA) is used in pharmaceutical intermediate applications such as the production of antibiotics and anti-inflammatory drugs. It also finds application in cosmetics such as hair care products, skin care products, and nail polish removers.
Pharmaceutical Grade LOLA accounted for the largest share of the global market in 2017 owing to its high purity levels which are required for pharmaceutical applications. The industrial grade LOLA segment accounted for a small share of the global market due to its lower purity levels which are suitable only for industrial purposes such as paint removers or degreasers.
Asia Pacific was one of the fastest growing regions with an estimated CAGR of 6% during 2018-2030 owing to increasing demand from emerging economies such as China and India coupled with rising awareness about health benefits associated with LOLA consumption among consumers across these countries.
- The growth of the L-ornithine L-aspartate (LOLA) market is driven by the increasing demand for protein supplements and dietary supplements in emerging economies such as China and India, which are witnessing an increase in disposable income levels and a growing awareness about health benefits of protein supplements and dietary supplements among consumers.
- Increasing awareness about the benefits of protein supplementation among consumers, especially in emerging economies such as China and India, is also driving the growth of this market.
- The increasing number of clinical trials on LOLA for various indications including cancer treatment, cardiovascular diseases, diabetes mellitus type 2, Alzheimer's disease etc, will provide opportunities for LOLA manufacturers to develop new products with improved efficacy.
- Increasing research activities on LOLA will lead to increased understanding about its mechanism of action which will help manufacturers develop better formulations.
Industry Growth Insights published a new data on “L-ornithine L-aspartate (LOLA) Market”. The research report is titled “L-ornithine L-aspartate (LOLA) Market research by Types (Pharmaceutical Grade, Industrial Grade), By Applications (Pharmaceutical Intermediate, Cosmetics, Dietary Supplement, Others), By Players/Companies Kyowa Hakko, Evonik, Shandong Jinyang Pharmaceutical, Beile Group, Nantong Puyer, Tianjing Jingye, Wuxi Jinghai Amino Acid, Zhejiang Fuyan Dongchen, Hebei Fangrui Biological, ACERBLEND”.
Scope Of The Report
Report Attributes
Report Details
Report Title
L-ornithine L-aspartate (LOLA) Market Research Report
By Type
Pharmaceutical Grade, Industrial Grade
By Application
Pharmaceutical Intermediate, Cosmetics, Dietary Supplement, Others
By Companies
Kyowa Hakko, Evonik, Shandong Jinyang Pharmaceutical, Beile Group, Nantong Puyer, Tianjing Jingye, Wuxi Jinghai Amino Acid, Zhejiang Fuyan Dongchen, Hebei Fangrui Biological, ACERBLEND
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
 Industry Outlook.svg)
Global L-ornithine L-aspartate (LOLA) Market Report Segments:
The global L-ornithine L-aspartate (LOLA) market is segmented on the basis of:
Types
Pharmaceutical Grade, Industrial Grade
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Intermediate, Cosmetics, Dietary Supplement, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kyowa Hakko
- Evonik
- Shandong Jinyang Pharmaceutical
- Beile Group
- Nantong Puyer
- Tianjing Jingye
- Wuxi Jinghai Amino Acid
- Zhejiang Fuyan Dongchen
- Hebei Fangrui Biological
- ACERBLEND
 Market Overview.svg)
Highlights of The L-ornithine L-aspartate (LOLA) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pharmaceutical Grade
- Industrial Grade
- By Application:
- Pharmaceutical Intermediate
- Cosmetics
- Dietary Supplement
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the L-ornithine L-aspartate (LOLA) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
L-ornithine L-aspartate (LOLA) is a form of the amino acid L-ornithine that has been esterified with aspartic acid. It is used in scientific research as a marker for brain activity.
Some of the key players operating in the l-ornithine l-aspartate (lola) market are Kyowa Hakko, Evonik, Shandong Jinyang Pharmaceutical, Beile Group, Nantong Puyer, Tianjing Jingye, Wuxi Jinghai Amino Acid, Zhejiang Fuyan Dongchen, Hebei Fangrui Biological, ACERBLEND.
The l-ornithine l-aspartate (lola) market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. L-ornithine L-aspartate (LOLA) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. L-ornithine L-aspartate (LOLA) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. L-ornithine L-aspartate (LOLA) Market - Supply Chain
4.5. Global L-ornithine L-aspartate (LOLA) Market Forecast
4.5.1. L-ornithine L-aspartate (LOLA) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. L-ornithine L-aspartate (LOLA) Market Size (000 Units) and Y-o-Y Growth
4.5.3. L-ornithine L-aspartate (LOLA) Market Absolute $ Opportunity
5. Global L-ornithine L-aspartate (LOLA) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Type
5.3.1. Pharmaceutical Grade
5.3.2. Industrial Grade
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global L-ornithine L-aspartate (LOLA) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical Intermediate
6.3.2. Cosmetics
6.3.3. Dietary Supplement
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global L-ornithine L-aspartate (LOLA) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global L-ornithine L-aspartate (LOLA) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global L-ornithine L-aspartate (LOLA) Demand Share Forecast, 2019-2026
9. North America L-ornithine L-aspartate (LOLA) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical Intermediate
9.4.2. Cosmetics
9.4.3. Dietary Supplement
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Type
9.7.1. Pharmaceutical Grade
9.7.2. Industrial Grade
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America L-ornithine L-aspartate (LOLA) Demand Share Forecast, 2019-2026
10. Latin America L-ornithine L-aspartate (LOLA) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical Intermediate
10.4.2. Cosmetics
10.4.3. Dietary Supplement
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Type
10.7.1. Pharmaceutical Grade
10.7.2. Industrial Grade
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America L-ornithine L-aspartate (LOLA) Demand Share Forecast, 2019-2026
11. Europe L-ornithine L-aspartate (LOLA) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical Intermediate
11.4.2. Cosmetics
11.4.3. Dietary Supplement
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Type
11.7.1. Pharmaceutical Grade
11.7.2. Industrial Grade
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe L-ornithine L-aspartate (LOLA) Demand Share, 2019-2026
12. Asia Pacific L-ornithine L-aspartate (LOLA) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical Intermediate
12.4.2. Cosmetics
12.4.3. Dietary Supplement
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Type
12.7.1. Pharmaceutical Grade
12.7.2. Industrial Grade
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific L-ornithine L-aspartate (LOLA) Demand Share, 2019-2026
13. Middle East & Africa L-ornithine L-aspartate (LOLA) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical Intermediate
13.4.2. Cosmetics
13.4.3. Dietary Supplement
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa L-ornithine L-aspartate (LOLA) Market Size and Volume Forecast by Type
13.7.1. Pharmaceutical Grade
13.7.2. Industrial Grade
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa L-ornithine L-aspartate (LOLA) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global L-ornithine L-aspartate (LOLA) Market: Market Share Analysis
14.2. L-ornithine L-aspartate (LOLA) Distributors and Customers
14.3. L-ornithine L-aspartate (LOLA) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Kyowa Hakko
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Evonik
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shandong Jinyang Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beile Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nantong Puyer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Tianjing Jingye
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Wuxi Jinghai Amino Acid
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zhejiang Fuyan Dongchen
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Hebei Fangrui Biological
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. ACERBLEND
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
